gastric emptying glp-1 Glucagon-like peptide-1 (GLP-1) receptor agonists are incretin analogues that promote glucose-mediated insulin release and are used to treat type 2 diabetes mellitus and #obesity. receptor agonists and GLP-1 and glucose-dependent insulinotropic Frontiers | GLP−1 receptor agonists

PV is generated via retail sales and a LifeVantage promoters own orders

Many successful outcomes involve gradual rather than dramatic initial changes

Take home points: Empagliflozin has a large study that shows a small but significant reduction in death and heart failure hospitalizations (NNT for primary outcome = 63 patients for ~3 years) compared to placebo in patients with diabetes and CV disease Empagliflozin can cause urinary and genital infections and ketoacidosis with near normal glucose Because of its mechanism (spilling glucose through the urine), it may develop a role in diabetes mellitus type 1 Refrences: American Diabetes Association: Standards of medical care in diabetes - 2016

Its usually outpatient, and most patients are back to normal life within a few days. The Bigger Picture: Why Healthy Weight Loss Still Matters Despite the potential gallbladder risks, Dr

Pola KK, Kumar Rada S